Literature DB >> 23036584

Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease.

James M Bullock1, Christopher Medway, Mario Cortina-Borja, James C Turton, Jonathan A Prince, Carla A Ibrahim-Verbaas, Maaike Schuur, Monique M Breteler, Cornelia M van Duijn, Patrick G Kehoe, Rachel Barber, Eliecer Coto, Victoria Alvarez, Panos Deloukas, Naomi Hammond, Onofre Combarros, Ignacio Mateo, Donald R Warden, Michael G Lehmann, Olivia Belbin, Kristelle Brown, Gordon K Wilcock, Reinhard Heun, Heike Kölsch, A David Smith, Donald J Lehmann, Kevin Morgan.   

Abstract

Despite recent discoveries in the genetics of sporadic Alzheimer's disease, there remains substantial "hidden heritability." It is thought that some of this missing heritability may be because of gene-gene, i.e., epistatic, interactions. We examined potential epistasis between 110 candidate polymorphisms in 1757 cases of Alzheimer's disease and 6294 control subjects of the Epistasis Project, divided between a discovery and a replication dataset. We found an epistatic interaction, between rs7483 in GSTM3 and rs1111875 in the HHEX/IDE/KIF11 gene cluster, with a closely similar, significant result in both datasets. The synergy factor (SF) in the combined dataset was 1.79, 95% confidence interval [CI], 1.35-2.36; p = 0.00004. Consistent interaction was also found in 7 out of the 8 additional subsets that we examined post hoc: i.e., it was shown in both North Europe and North Spain, in both men and women, in both those with and without the ε4 allele of apolipoprotein E, and in people older than 75 years (SF, 2.27; 95% CI, 1.60-3.20; p < 0.00001), but not in those younger than 75 years (SF, 1.06; 95% CI, 0.59-1.91; p = 0.84). The association with Alzheimer's disease was purely epistatic with neither polymorphism showing an independent effect: odds ratio, 1.0; p ≥ 0.7. Indeed, each factor was associated with protection in the absence of the other factor, but with risk in its presence. In conclusion, this epistatic interaction showed a high degree of consistency when stratifying by sex, the ε4 allele of apolipoprotein E genotype, and geographic region.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23036584     DOI: 10.1016/j.neurobiolaging.2012.08.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

1.  Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions.

Authors:  Mark T W Ebbert; Perry G Ridge; Andrew R Wilson; Aaron R Sharp; Matthew Bailey; Maria C Norton; JoAnn T Tschanz; Ronald G Munger; Christopher D Corcoran; John S K Kauwe
Journal:  Biol Psychiatry       Date:  2013-08-13       Impact factor: 13.382

2.  Glutathione S-transferases variants as risk factors in Alzheimer's disease.

Authors:  Tengfei Wang
Journal:  Neurol Sci       Date:  2015-05-17       Impact factor: 3.307

3.  Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort.

Authors:  Elizabeth Vance; Josue D Gonzalez Murcia; Justin B Miller; Lyndsay Staley; Paul K Crane; Shubhabrata Mukherjee; John S K Kauwe
Journal:  Neurobiol Aging       Date:  2020-02-12       Impact factor: 4.673

Review 4.  Genetic variants in Alzheimer disease - molecular and brain network approaches.

Authors:  Chris Gaiteri; Sara Mostafavi; Christopher J Honey; Philip L De Jager; David A Bennett
Journal:  Nat Rev Neurol       Date:  2016-06-10       Impact factor: 42.937

Review 5.  Bridging the gap between statistical and biological epistasis in Alzheimer's disease.

Authors:  Mark T W Ebbert; Perry G Ridge; John S K Kauwe
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

6.  Kinesin family member 11 contributes to the progression and prognosis of human breast cancer.

Authors:  Yuan-Yuan Pei; Gao-Chi Li; Jian Ran; Feng-Xiang Wei
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

7.  Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.

Authors:  Mark T W Ebbert; Kevin L Boehme; Mark E Wadsworth; Lyndsay A Staley; Shubhabrata Mukherjee; Paul K Crane; Perry G Ridge; John S K Kauwe
Journal:  Alzheimers Dement       Date:  2015-10-09       Impact factor: 21.566

Review 8.  Detecting epistasis in human complex traits.

Authors:  Wen-Hua Wei; Gibran Hemani; Chris S Haley
Journal:  Nat Rev Genet       Date:  2014-09-09       Impact factor: 53.242

Review 9.  Additional mechanisms conferring genetic susceptibility to Alzheimer's disease.

Authors:  Miguel Calero; Alberto Gómez-Ramos; Olga Calero; Eduardo Soriano; Jesús Avila; Miguel Medina
Journal:  Front Cell Neurosci       Date:  2015-04-09       Impact factor: 5.505

Review 10.  Genetics of Alzheimer's disease.

Authors:  Perry G Ridge; Mark T W Ebbert; John S K Kauwe
Journal:  Biomed Res Int       Date:  2013-07-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.